Vectus Biosystems Ltd
VBS•Health Care•Biotechnology•Last updated: Dec 25
About
Vectus Biosystems Ltd is a biotechnology company focused on developing treatments for fibrosis and high blood pressure. The company is engaged in the research and development of novel compounds that target fibrosis in organs such as the heart, kidneys, and liver. Vectus Biosystems' lead product candidate is VB0004, which is designed to treat fibrosis and hypertension.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- VBS
Related Shares
Investor Resources
Should you buy Vectus Biosystems Ltd right now?
While VBS looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now